Vulnerable atherosclerotic plaque: Emerging challenge for animal models

Current Opinion in Cardiology

Volumn 17, Issue 6, 2002, Pages 626-632

  Rekhter, Mark ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOMECHANICS; BLEEDING; COLLAGEN SYNTHESIS; CORONARY ARTERY DISEASE; INFLAMMATION; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RUPTURE; THROMBOSIS;

ANIMALS; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; DISEASE MODELS, ANIMAL; MODELS, CARDIOVASCULAR;

EID: 0036871794     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200211000-00008     Document Type: Review

References (73)

1. Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372. • This is the most comprehensive and current review related to plaque vulnerability that provides a context for animal modeling.
2. Prescott MF, McBride CH, Hasler RJ, et al.: Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 1991, 139:139-147.
3. Gerrity RG, Natarajan R, Nadler JL, et al.: Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001, 50:1654-1665.
4. Calara F, Silvestre M, Casanada F, et al.: Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 2001, 195:257-263.
5. Rosenfeld MA, Polinsky P, Virmani IR, et al.: Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mice. Arterioscler Thromb Vasc Biol 2000, 20:2587-2592.
6. Johnson JL, Jackson CL: Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 2001, 154:399-406.
7. Williams H, Johnson JL, Carson KGS, et al.: Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2002, 22:788-792. •• This study describes high frequency of spontaneous plaque rupture in the brachiocephalic artery of Apo E-/- mice fed high cholesterol diet.
8. Braun A, Trigatti BL, Post MJ, et al.: Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002, 90:270-276. •• This study demonstrates that Apo E deficiency combined with SR-BI, an HDL receptor, deficiency leads to detrimental cardiovascular events, including mural thrombosis associated with advanced coronary lesions.
9. Herrera VL, Makrides SC, Xie HX, et al.: Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat Med 1999, 5:1383-1389.
10. Reddick RL, Zhang SH, Maeda N: Aortic atherosclerotic plaque injury in apolipoprotein E deficient mice. Atherosclerosis 1998, 140:297-305.
11. Gertz SD, Fallon JT, Gallo R, et al.: Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries. Circulation 1998, 98:580-587.
12. Rekhter MD, Hicks GW, Brammer DW, et al.: Animal model that mimics atherosclerotic plaque rupture. Circ Res 1998, 83:705-713.
13. Eitzman DT, Westrick RJ, Xu Z, et al.: Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000, 20:1831-1834.
14. Constantinides P, Chakravarti RN: Rabbit arterial thrombosis production by systemic procedures. Arch Pathol 1961, 72:197-208.
15. Abela GS, Picon PD, Friedl SE, et al.: Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation 1995, 91:776-784.
16. Nakamura M, Abe S, Kinukawa N: Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II. Atherosclerosis 1997, 128:149-156.
17. Caligiuri G, Levy B, Pernow J, et al.: Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A 1999, 96:6920-6924.
18. Rekhter MD, Labatzky S, Meltzer L, et al.: Plaque rupture, thrombosis and paraplegia are triggered by corticotropin releasing factor: a pilot study in mice. J Submicrosc Cytol Pathol 2000, 32:415.
19. von der Thusen JH, van Vlijmen BJ, Hoeben RC, et al.: Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 2002, 105:2064-2070. •• First direct demonstration that p53-induced apoptosis of fibrous cap SMCs leads to fibrous cap thinning and makes the plaque prone to induced rupture.
20. Virmani R, Kolodgie FD, Burke AP, et al.: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275.
21. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995, 91:2844-2850.
22. Davies MJ, Thomas AC: Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985, 53:363-373.
23. Fuster V, Stein B, Ambrose JA, et al.: Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 1990, 82:1147-59.
24. Rekhter MD, Hicks GW, Brammer DW, et al.: Hypercholesterolemia causes mechanical weakening of rabbit atheroma. Local collagen loss as a prerequisite of plaque rupture. Circ Res 2000, 86:101-108.
25. Saijo Y, Jorgensen CS, Falk E: Ultrasonic tissue characterization of collagen in lipid-rich plaques in apoE-deficient mice. Atherosclerosis 2001, 158:289-295.
26. de-Korte CL, van-der-Steen AF, Cepedes El, et al.: Characterization of plaque components and vulnerability with intravascular ultrasound elastography. Phys Med Biol 2000, 45:1465-1475.
27. de Korte CL, Sierevogel MJ, Mastik F, et al.: identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation 2002, 105:1627-1630.
28. Kolodgie FD, Burke AP, Farb A, et al.: The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001, 16:285-292.
29. Shiomi M, Ito T, Hirouchi Y, et al.: Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Atherosclerosis 2001, 157:75-84.
30. Yuan C, Kerwin WS, Ferguson MS, et al.: Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002, 15:62-67.
31. Nissen SE: Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. Am J Cardiol 2002, 89:24B-31B.
32. Small DM: George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. Arteriosclerosis 1988, 8:103-129.
33. Moreno PR, Lodder RA, Purushothaman KR, et al.: Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation 2002, 105:923-927.
34. Aikawa M, Rabkin E, Okada Y, et al.: Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998, 97:2433-2444.
35. Rekhter MD: Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res 1999, 41:376-384.
36. Nakata Y, Maeda N: Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation 2002, 105:1485-1490. • This study provides evidence that deficiency of collagen synthesis can influence plaque phenotype. In genetically engineered hypercholesterolemic, scorbutic mice, the authors observed decreased collagen content in the plaques with no change in lesion size.
37. Sukhova GK, Schonbeck U, Rabkin E, et al.: Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999, 99:2503-2509.
38. Strauss BH, Robinson R, Batchelor WB, et al.: In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res 1996, 79:541-550.
39. Chen J, Kindt E, Hallak H, et al.: Molecular sieving and mass spectroscopy reveal enhanced collagen degradation in rabbit atheroma. Atherosclerosis 2001, 159:289-295.
40. Risteli J, Risteli L: Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995, 22:77-81.
41. van der Wal AC, Becker AE, van der Loos CM, et al.: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
42. Galis ZS, Sukhova GK, Kranzhofer R, et al.: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 1995, 92:402-406.
43. Sukhova GK, Shi GP, Simon DI, et al.: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998, 102:576-583.
44. Amento EP, Ehsani N, Palmer H, et al.: Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991, 11:1223-1230.
45. Herman MP, Sukhova GK, Libby P, et al.: Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 2001, 104:1899-1904.
46. Pasterkamp G, Schoneveld AH, van der Wal AC, et al.: Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arterioscler Thromb Vasc Biol 1999, 19:54-58.
47. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262. • Excellent review discussing potential role of metalloproteinases in plaque vulnerability.
48. Lemaitre V, O'Byrne TK, Borczuk AC, et al.: ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001, 107:1227-1234. • Important reality check showing that changing one, presumably critical, "vulnerability" factor (overexpression of collagenase) may not be sufficient for plaque rupture.
49. Silence J, Collen D, Lijnen HR: Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 2002, 90:897-903.
50. Ruehm SG, Corot C, Vogt P, et al.: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001, 103:415-422.
51. Rudd JHF, Warburton EA, Fryer TD, et al.: Imaging atherosclerotic plaque inflammation with [18f]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 01.
52. Chen J, Tung CH, Mahmood U, et al.: In vivo imaging of proteolytic activity in atherosclerosis. Published online before print, May 13, 2002. (Circulation 2002, 10.1161/01.CIR.0000017860.20619.23) •• This is a pioneering study enabling in vivo visualization of proteolytic activities in mouse atherosclerotic plaques.
53. Verheye S, De Meyer GRY, Van Langenhove G, et al.: In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation 2002, 105:1596-1601.
54. Naghavi M, Madjid M, Khan MR, et al.: New developments in the detection of vulnerable plaque. Curr Atheroscler Rep 2001, 3:125-135.
55. Taubman MB, Fallon JT, Schecter AD, et al.: Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997, 78:200-204.
56. Aikawa M, Voglic SJ, Sugiyama S, et al.: Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation 1999, 100:1215-1222.
57. Aikawa M, Rabkin E, Sugiyama S, et al.: An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001, 103:276-283. • This is a good example of using thrombosis-related "vulnerability endpoints" in drug studies. Specifically, the article demonstrates plaque-stabilizing properties of statins.
58. Baetta R, Camera M, Comparato C, et al.: Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterolfed rabbits in the absence of lipid lowering. Arterioscler Thromb Vasc Biol 2002, 22:692-698.
59. Bennett MR, Evan GI, Schwartz SM: Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995, 95:2266-2274.
60. Aikawa M, Rabkin E, Voglic SJ, et al.: Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998, 83:1015-1026.
61. Schonbeck U, Libby P: CD40 signaling and plaque instability. Circ Res 2001, 89:1092-1103.
62. Lutgens E, Cleutjens KBJM, Heeneman S, et al.: Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci U S A 2000, 97:7464-7469.
63. Mallat Z, Corbaz A, Scoazec A, et al.: Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001, 89:E41-E45.
64. Mallat Z, Gojova A, Marchiol-Fournigault C, et al.: Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001, 89:930-934. • This is a good example of using "vulnerability endpoints" in mechanistic studies.
65. Matetzky S, Tani S, Kangavari S, et al.: Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation 2000, 102:602-604.
66. Zhou J, Moller J, Danielsen CC, et al.: Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in apoE-deficient mice. Arterioscler Thromb Vasc Biol 2001, 21:1470-1476.
67. Shah PK, Yano J, Reyes O, et al.: High-dose recombinant apolipoprotein A-l(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 2001, 103:3047-3050.
68. Fukumoto Y, Libby P, Rabkin E, et al.: Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation 2001, 103:993-999.
69. Purcell MK, Mu JL, Higgins DC, et al.: Fine mapping of Ath6, a quantitative trait locus for atherosclerosis in mice. Mamm Genome 2001, 12:495-500.
70. Welch CL, Bretschger S, Latib N, et al.: Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci U S A 2001, 98:7946-7951.
71. Mehrabian M, Wong J, Wang X, et al.: Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res 2001, 89:125-130.
72. Harrap SB, Zammit KS, Wong ZYH, et al.: Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 2002, 22:874-878.
73. Faber BCG, Cleutjens KBJM, Niessen RLJ, et al.: Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res 2001, 89:547-554.